Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ayşegül ÜNER"'
Autor:
Müfide Okay, Tuncay Aslan, Evren Özdemir, Ayşegül Üner, Arzu Sağlam, Elif Güngör, Ayşe Uysal, Nevin Alayvaz Aslan, Esra Yıldızhan, Abdullah Ağıt, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroğlu, Serdar Sivgin, Gülsüm Akgün Cağlıyan
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 2, Pp 84-90 (2020)
Objective: Chronic antigenic stimulation is frequently blamed in the pathogenesis of extranodal marginal zone lymphomas including splenic marginal zone lymphoma (SMZL). Chronic hepatitis C is frequently observed in SMZL patients in some geographical
Externí odkaz:
https://doaj.org/article/ec6a87f1038f485a9ea4ce237c1fe371
Autor:
Gamze Durhan, Aynur Azizova, Ömer Önder, Kemal Kösemehmetoğlu, Jale Karakaya, Meltem Gülsün Akpınar, Figen Demirkazık, Ayşegül Üner
Publikováno v:
European Journal of Breast Health, Vol 15, Iss 3, Pp 147-152 (2019)
Objective: The aim of this study was to evaluate the clinical, imaging and histopathological features of breast cancer in patients aged under 40 years of age. The relationship between radiological characteristics and histopathological features was al
Externí odkaz:
https://doaj.org/article/bc8e2db3e9244c4ba5d1ccb1cea5afa1
Autor:
Muhammed B. Jaiteh, Nursel Çalık Başaran, Lale Özışık, Orkun Akman, Nasib Hasanlı, Sema Tortop, Büşra Betül Özmen Çapın, Sabine Hüseyinova, Ayşegül Üner, Ahmet Çağkan İnkaya
Publikováno v:
Türkiye Parazitoloji Dergisi, Vol 43, Iss 4, Pp 210-212 (2019)
Leishmaniasis is a neglected disease that is prevalent in tropical and subtropical regions of the world. Even though cutaneous leishmaniasis is the most common form, visceral leishmaniasis is associated with high mortality. The case presented herein
Externí odkaz:
https://doaj.org/article/73406210c1f94415a2a804af185120f5
Publikováno v:
Turkish Journal of Hematology, Vol 36, Iss 1, Pp 57-59 (2019)
Externí odkaz:
https://doaj.org/article/cc88a421da1f4d8e99aa98f2361145b6
Autor:
Özlen Bektaş, Ayşegül Üner, Eylem Eliaçık, Burak Uz, Ayşe Işık, Sezgin Etgül, Süreyya Bozkurt, İbrahim Celalettin Haznedaroğlu, Hakan Göker, Nilgün Sayınalp, Salih Aksu, Haluk Demiroğlu, Osman İlhami Özcebe, Yahya Büyükaşık
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 2, Pp 119-126 (2016)
INTRODUCTION: Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease. Patients are at risk of developing cytopenias or progression to acute myeloid leukemia. Different classifications and prognostic scoring systems have been devel
Externí odkaz:
https://doaj.org/article/eae90f16f7474ea8918d50cc6440d113
Autor:
Eylem Eliaçık, Ayşe Işık, Salih Aksu, Ayşegül Üner, Yahya Büyükaşık, Nilgün Sayınalp, Hakan Göker, Osman İ. Özcebe, İbrahim C. Haznedaroğlu
Publikováno v:
Turkish Journal of Hematology, Vol 32, Iss 2, Pp 163-167 (2015)
Ruxolitinib, JAK1 ve JAK2 inhibitörü olarak işlev gören bir ilaçtır. Semptomatik splenomegalisi olan orta- veya yüksek-risk myelofibrozis hastalarında kullanımı uluslararası onam almıştır. Bu bağlamda ruxolitinib, Philadelphia kromozom
Externí odkaz:
https://doaj.org/article/1fa5090ab1fa42cd843fac7026338c06
Publikováno v:
Turkish Archives of Otorhinolaryngology, Vol 41, Iss 2, Pp 100-103 (2003)
Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis) is a benign self-limiting disease with unknown aetiology. It is characterized by enlargement of lymph nodes, which may be tender and can be accompanied by fever and other upper respirat
Externí odkaz:
https://doaj.org/article/c406a44d0854475a9cd048d14367413e
Autor:
Hasan Çağrı YILDIRIM, Meral ÜNER, Tuğba YILDIRAN ÖZMEN, Elvin CHALABIYEV, Deniz Can GÜVEN, Fatih KUŞ, Arif AKYILDIZ, Feride YILMAZ, Serkan YAŞAR, Yasemin EVLENDİ, Ömer DİZDAR, Şuayib YALÇIN, Ayşegül ÜNER, Sercan AKSOY
Publikováno v:
Journal of Oncological Sciences. 9:33-37
Autor:
Özgür Şahin, Yasser Riazalhosseini, Caglar Cekic, Ayşegül Üner, Stefan Wiemann, Pouria Jandaghi, Özge Saatci, Erol Eyüpoğlu, Ünal M. Tokat, Pelin G. Ersan, Umar Raza, Hilal Bal, Merve Kayhan, Suhail A. Ansari, Nevin Belder, Rasmi R. Mishra
Purpose: Tamoxifen remains an important hormonal therapy for ER-positive breast cancer; however, development of resistance is a major obstacle in clinics. Here, we aimed to identify novel mechanisms of tamoxifen resistance and provide actionable drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c4505ce1f1493836439041dc57ecfca
https://doi.org/10.1158/1078-0432.c.6525675.v1
https://doi.org/10.1158/1078-0432.c.6525675.v1
Autor:
Özgür Şahin, Yasser Riazalhosseini, Caglar Cekic, Ayşegül Üner, Stefan Wiemann, Pouria Jandaghi, Özge Saatci, Erol Eyüpoğlu, Ünal M. Tokat, Pelin G. Ersan, Umar Raza, Hilal Bal, Merve Kayhan, Suhail A. Ansari, Nevin Belder, Rasmi R. Mishra
Mishra and Sahin patent info for Conflict of Interest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c684eb7fe4476b2c415384f6656792a
https://doi.org/10.1158/1078-0432.22464333.v1
https://doi.org/10.1158/1078-0432.22464333.v1